E. Claire Dees

Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies

Neil L. Spector, Wenle Xia, Howard A. Burris et al. · Journal of Clinical Oncology · 2005 · 363 citations · Full text

Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study

Bohuslav Melichar, Antoine Adenis, A. Craig Lockhart et al. · The Lancet Oncology · 2015 · 248 citations

Investigational Aurora, Medicine, Pharmacology +7

The interaction of post‐traumatic growth and post‐traumatic stress symptoms in predicting depressive symptoms and quality of life

Edward Forrest Morrill, Noel T. Brewer, Suzanne C. O’Neill et al. · Psycho-Oncology · 2008 · 246 citations

Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301

Antonius A. Miller, Daryl J. Murry, Kouros Owzar et al. · Journal of Clinical Oncology · 2009 · 207 citations · Full text

Phase I Dose-Escalation Study of LCL161, an Oral Inhibitor of Apoptosis Proteins Inhibitor, in Patients With Advanced Solid Tumors

Jeffrey R. Infante, E. Claire Dees, Anthony J. Olszanski et al. · Journal of Clinical Oncology · 2014 · 205 citations · Full text